Solo Oil takes stake in Helium One, providing commodity diversification

|

Published 23-MAR-2017 12:26 P.M.

|

4 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.


Click Here to View Latest Articles

Solo Oil plc (AIM: SOLO), a natural resources investment company focused on acquiring and developing a diverse global non-operated portfolio of strategic oil and gas assets has negotiated the acquisition of a 10% interest in Helium One Limited for a total consideration of £2.55 million.

Solo has also been granted a 90-day call option to increase its investment in Helium One by a further 10%, for an additional investment of £4 million, which would increase its stake to 20%.

Consideration for the initial investment is by way of £1.2 million in cash and £1.35 million in ordinary shares. Should Solo exercise its call option to increase its interest in Helium One to 20%, the group will pay £2 million in cash and issue new ordinary shares to the value of $2 million.

It should be noted here that this is an early stage play for the company, so investors should take a cautious approach to their investment decision and take all publicly available information into account.

Transaction diversifies product portfolio while leveraging off its understanding of the Tanzanian market

Solo has an established presence in Tanzania through its Kiliwani North gas production project and a 25% working interest in the Ntorya gas-condensate discovery.

Consequently, its interest in Helium One provides exposure to a region that is well understood, while expanding into helium as a complementary energy product that aligns with its oil and gas assets.

On this note, Solo’s chairman, Neil Ritson said, “Solo has successfully invested in bringing several gas projects to market in Tanzania which are now reaching maturity from an investment viewpoint, and given the related pricing of petroleum gas and helium, which is globally in short supply Solo has for some time been investigating opportunities in that sector.”

Ritson highlighted the fact that Helium One’s portfolio of prospective helium projects in Tanzania provides the group with a unique early stage investment into a potentially world-scale helium resource.

Helium One’s Rukwa project located in Tanzania has independently been estimated by Netherland based Sewell and Associates Inc to contain unrisked most likely prospective recoverable helium volumes close to 100 billion cubic feet (BCF).

Ritson is of the view that Rukwa, together with Helium One’s additional project areas at Eyasi and Balangida represent an attractive strategic investment, especially given the helium market’s weak supply dynamics and continued demand growth.

Helium supply failing to keep up with increasing demand

Solo noted that global demand for helium is growing at a rate that is outstripping supply, presenting a significant pricing opportunity for future producers.

Looking at the supply side of the equation, it is concentrated in only a few markets, mainly Algeria, Australia, Russia, Qatar and the US. While the US dominated the market throughout the twentieth century and remains the largest global supplier (circa 60% in 2015), the government’s decision to relinquish control of its assets has resulted in the majority of global helium production being sourced as a by-product from other gas producing streams. Qatar is the second largest global supplier, accounting for 24% in 2015.

Naturally occurring helium rich assets hold considerable advantages, and from a geological standpoint Tanzania has been identified as a key country for helium exploration based on the evidence of surface gas seeps in the geological rift valleys adjacent to the Tanzanian Craton.

This location is ideal in terms of potentially exporting the product given its proximity to the deepwater port at Dar es Salaam.

Helium has applications in a broad range of markets and cannot be substituted

The use of helium is essential in many modern industries, ranging from cryogenics (including use in MRI scanners), to lifting and electronic applications.

As these industries grow, in conjunction with many others, the demand for helium which has been rising rapidly for the last decade is set to continue.

Helium cannot be readily substituted due to its unique properties being inert, non-toxic, and lighter than air and with an incredibly low boiling point of minus 269 degrees centigrade (just 4 degrees above absolute zero).

Current global demand is estimated to be over 6 billion standard cubic feet per annum. The price of bulk liquid helium has risen by more than 100% over the past 10 years.

Following a shortage of helium between 2011 and 2013, the introduction of supply from the Qatar 11 plant in 2014-2015 resulted in two years of oversupply. However, equilibrium returned in 2016 and the forward supply demand dynamics are looking strong.



General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.

 

Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free

X